ABN401
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABN401, covering 2025-01-06 to 2025-05-22. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation [Phase 2]